MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Allscripts Healthcare Solutions Company Profile (NASDAQ:MDRX)

Consensus Ratings for Allscripts Healthcare Solutions (NASDAQ:MDRX) (?)
Ratings Breakdown: 8 Hold Rating(s), 11 Buy Rating(s)
Consensus Rating:Buy (Score: 2.58)
Consensus Price Target: $15.92 (19.58% upside)

Analysts' Ratings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Show:
DateFirmActionRatingPrice TargetActions
4/17/2016Deutsche BankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2016Morgan StanleyInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2016Jefferies GroupReiterated RatingBuy$16.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2016Canaccord GenuityReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016FBR & Co.Reiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016SunTrustLower Price TargetBuy$18.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Leerink SwannLower Price Target$17.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Goldman SachsLower Price TargetNeutral$15.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Cowen and CompanyLower Price TargetOutperform$18.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016BarclaysLower Price TargetEqual Weight$15.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016RBC CapitalReiterated RatingOutperform$19.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2016ArgusBoost Price TargetBuy$17.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2016Topeka Capital MarketsBoost Price TargetHold$14.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/4/2016Raymond JamesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2015JPMorgan Chase & Co.Initiated CoverageOverweight$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Evercore ISIBoost Price TargetHold$14.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Avondale PartnersInitiated CoverageOutperform$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015OppenheimerReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Credit SuisseReiterated RatingOutperform$15.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015Piper JaffrayUpgradeUnderweight -> Neutral$9.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2015Stifel NicolausInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2015Robert W. BairdInitiated CoverageOutperform$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Citigroup Inc.Reiterated RatingNeutral$17.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014Wells FargoReiterated RatingMarket Perform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014B. RileyLower Price TargetNeutral -> Neutral$18.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/6/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha